Howard Fillit, MD: Funding Clinical Trials for Alzheimer's Disease
Howard Fillit, MD, spoke about the struggles to get clinical trials funded in Alzheimer's Disease.
Read More
Howard Fillit, MD: Physician Burden in Treating Patients with Alzheimer's Disease
Howard Fillit, MD, discussed the burden faced by physicians that treat patients with Alzheimer's Disease.
Mandatory Screening Reduces Risk of Infant Death Due to CCHD
States with mandatory screening programs experienced a 33.4% reduced rate of infant deaths due to critical congenital heart disease.
FDA Approves Molecular Test for Valley Fever
The test provides same-day results, compared to the 21-day time to results of current diagnostic methods.
Howard Fillit, MD: Repurposing Therapies for Alzheimer Disease
Howard Fillit, MD, discussed the state of therapies for Alzheimer Disease, and the need for repurposed drugs sooner rather than later.
FDA Approves Evolocumab for Cardiovascular Events Risk Reduction
After being granted a Priority Review designation, the PCSK9 inhibitor has been approved for risk reduction of heart attack, stroke, and coronary revascularization.
PROMISE 2 Explores Eptinezumab for Chronic Migraine
Eptinezumab, a monoclonal antibody, has shown impressive results in previous clinical trials, giving high hopes for the PROMISE 2 trial.
Fremanezumab Shows Positive Results for Chronic Migraine
The monoclonal antibody reportedly reduced headache days by 4.3 and 4.6 days for the 625 mg and 225 mg doses, respectively.
Can SVC Decline Predict Clinical Events in ALS?
Retrospective analysis suggests that slow vital capacity may have prognostic value when it comes to amyotrophic lateral sclerosis.
Dronabinol Improves Sleep Apnea Outcomes
The synthetic, pill version of Delta-9 THC showed a reduction in AHI of more than 10 events per hour with both 2.5 mg and 10 mg doses.
Alex Azar Testifies in First Committee Hearing
Health and Human Services Secretary nominee Alex Azar spoke in front of the Congressional Committee for the first time on Wednesday.
Reddit Provides Physicians Opportunity to Educate, Connect
Reddit's Ask Me Anything forums have proven to give physicians a chance to connect with and educate thousands of people at once.
CVS Health to Provide Real-Time Prescription Information
Prescribing physicians and pharmacists will have access to individual-specific data on drug costs and alternatives in real-time with the new program.
Alex Azar Nomination for HHS Causes Controversy
Alex Azar's nomination for secretary of Health and Human Services has been met with controversy due to his ties to the pharmaceutical industry.
Prolonged Concussion Symptoms Identifiable by Salivary MicroRNA
5 microRNAs could successfully confirm PCS with 85% accuracy, outperforming the standard patient survey measures of symptom burden.
FDA Approves Azure Pacemaker Line
Medtronic’s Azure XT MRI and Azure S MRI pacemakers improved longevity by 27% compared to available predecessors.
High Incidence of PTSD Among Cancer Patients
33% of patients that were diagnosed with PTSD were still experiencing persistent symptoms - in many cases worsening - at 4-year follow-up.
Steve Levine, MD: The Challenges of Treating MDD
Steve Levine, MD, discussed the challenges physicians must overcome when treating patients with major depressive disorder.
Steve Levine, MD: How Close Are We to Personalized Medicine?
Steve Levine, MD, discussed the exciting future of personalized medicine and what sort of methods are currently at our disposal to personalize treatment for specific patients.
Baylor Scott & White Health Takes Comprehensive Approach to Heart Failure
Heart Failure: The Complexities of Treating a Complicated Condition
Mental Health Treatment Improves With Steps Toward Collaborative Care
Steve Levine, MD: Unmet Needs and Advances in MDD
Steve Levine, MD, discusses what unmet needs remain in major depressive disorder and how the advancements of the last decade are seeking to fill the holes that remain.
CTE Confirmed in Living Patient for First Time
As a result of these data, further evaluation in the form of clinical trials is “warranted,” according to the authors.
Steve Levine, MD: Ketamine's Role in Solving the Opioid Crisis
The United States's opioid epidemic may have help from ketamine - a common therapy for major depressive disorder.
Lifestyle Modification Shows Long-Term Benefits for T2D
Lifestyle modification was associated with a relative risk reduction of 39% compared to 36% for medications.
Canagliflozin Reduces CV Risk Regardless of CVD History
Both patients with and patients without a history of cardiovascular events experienced a reduced risk of multiple cardiovascular-related outcomes.
Sacubitril/Valsartan Decreases NT-proBNP, Increases NYHA Class
The drug showed a 30% decrease in NT-proBNP, a blood marker for HFrEF.
AHA, ACC Release New Hypertension Guidelines
The new guidelines define Stage 1 hypertension as a patient having systolic blood pressure between 130-139 or diastolic blood pressure between 80-89.
Web-Based Interventions Improve Diet, Weight in Patients With T2D
The ANODE program showed positive results in weight loss and Internation Diet Quality Index score.